Molecular vehicles for targeted drug delivery

Bioconjugate Chemistry

Volumn 13, Issue 3, 2002, Pages 462-467

  Backer, Marina V ^a   Aloise, Renee ^a   Przekop, Kristen ^a   Stoletov, Konstantin ^b   Backer, Joseph M ^a  

^a SIBTECH INC   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL MODIFICATION; CONTROLLED DRUG DELIVERY; ENDOTHELIAL CELLS; GENE THERAPY; GENE TRANSFER; RECOMBINANT PROTEINS; VEHICLES;

ADAPTER PROTEINS; CYTOKINES; DRUG CARRIER; DRUG DELIVERY VEHICLES; DRUG EFFICACY; NONCOVALENT BINDING; NOVEL STRATEGIES; PAYLOAD MODULES; RIBONUCLEASE A; SIDE EFFECT;

TARGETED DRUG DELIVERY;

BOVINAE;

ENDOTHELIAL CELL GROWTH FACTOR; HYBRID PROTEIN; LIPOSOME; LYMPHOKINE; PEPTIDE FRAGMENT; POLYETHYLENEIMINE; RIBONUCLEASE; RIBONUCLEASE S-PEPTIDE; S PEPTIDE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETICS; HUMAN; METABOLISM; PLASMID;

ANIMALS; CATTLE; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOSOMES; LYMPHOKINES; PEPTIDE FRAGMENTS; PLASMIDS; POLYETHYLENEIMINE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RIBONUCLEASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036000117     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0155770     Document Type: Article

References (24)

1. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
2. Development of new biotin/streptavidin reagents for pretargeting
3. Bispecific and bifunctional single chain recombinant antibodies
4. Tumor pretargeting for radioimmunodetection and radioimmunotherapy
5. Molecular vehicle for target-mediated delivery of therapeutics and diagnostics
6. Targeting endothelial cells overexpressing VEGFR-2: Selective toxicity of Shiga-like toxin-VEGF fusion proteins
7. Functionally active VEGF fusion proteins
8. Receptor-selective variants of human vascular endothelial growth factor
9. Ribonuclease S-peptide as a carrier in fusion proteins
10. Native-state hydrogen-exchange studies of a fragment complex can provide structural information about the isolated fragments
11. Thermodynamics of protein-peptide interactions in the ribonuclease S system studied by titration calorimetry
12. Refinement of the crystal structure of ribonuclease S. Comparison with and between the various ribonuclease A structures
13. Vascular permeability factor (VPF, VEGF) in tumor biology
14. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/ VEGF-expressing tumors and adenoviral vectors
15. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
16. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis
17. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells
18. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
19. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo
20. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine
21. From genes to gene medicines: Recent advances in nonviral gene delivery
22. Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system
23. Caspases: The executioners of apoptosis